[Corrigendum] Next‑generation sequencing analysis reveals that MTH‑3, a novel curcuminoid derivative, suppresses the invasion of MDA‑MB‑231 triple‑negative breast adenocarcinoma cells
- Authors:
- Published online on: June 3, 2024 https://doi.org/10.3892/or.2024.8750
- Article Number: 91
-
Copyright : © Chiu et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].
Article
Oncol Rep 46: [Related article:] 133, 2021; DOI: 10.3892/or.2021.8084
Subsequently to the publication of the article, an interested reader drew to the authors’ attention that, in Fig. 2A on p. 5, the ‘Control (24 h)’ and ‘MTH-3 (1 μM; 24 h)’ data panels contained partially overlapping data, such that they appeared to have been derived from the same original source. The authors have examined their original data, and realized that this error arose inadvertently as a consequence of having compiled this figure incorrectly.
The revised version of Fig. 2, featuring the data from one of the repeated experiments in Fig. 2A, is shown below. The revised data shown for this figure do not affect the overall conclusions reported in the paper. The authors apologize to the Editor of Oncology Reports and to the readership for any inconvenience caused.